| Concomitant |
| Product Used For Unknown Indication |
47.6% |
| Premedication |
19.2% |
| Gout |
7.6% |
| Allergy Prophylaxis |
4.2% |
| Pain |
3.8% |
| Hepatitis C |
2.7% |
| Rheumatoid Arthritis |
2.6% |
| Hypertension |
1.7% |
| Prophylaxis |
1.3% |
| Multiple Sclerosis |
1.1% |
| Anxiety |
1.0% |
| Osteoporosis |
1.0% |
| Gouty Tophus |
0.9% |
| Ill-defined Disorder |
0.9% |
| Osteoporosis Postmenopausal |
0.9% |
| Constipation |
0.8% |
| Psoriatic Arthropathy |
0.7% |
| Nausea |
0.7% |
| Pyrexia |
0.7% |
| Diabetes Mellitus |
0.7% |
|
| Therapeutic Response Decreased |
18.3% |
| Vomiting |
9.1% |
| Infusion Related Reaction |
7.9% |
| Drug Ineffective |
7.6% |
| Sinusitis |
6.1% |
| Weight Decreased |
6.1% |
| Pneumonia |
4.0% |
| Pyrexia |
4.0% |
| Urinary Tract Infection |
4.0% |
| Injection Site Pain |
3.7% |
| Pain In Extremity |
3.7% |
| Headache |
3.4% |
| Pain |
3.4% |
| Urticaria |
3.4% |
| Upper Respiratory Tract Infection |
3.0% |
| Injection Site Swelling |
2.7% |
| Nasopharyngitis |
2.4% |
| Nausea |
2.4% |
| Rash |
2.4% |
| Weight Increased |
2.4% |
|
